RefleXion Medical closes $46mm Series B round; round extended to $52mm
RefleXion Medical Inc. (guided radiotherapy for cancer) raised $46mm through its Series B round from lead investor KCK Group and returning backers Pfizer Venture Investments, Venrock, and Sofinnova Partners. KCK takes two board seats. Funds will support continued development and expansion of the company's technologies that utilize positron emission tomography (PET) to guide radiotherapy treatment.
- Medical Devices
- Private Placement
Please contact Sales at: (212) 520-2765 or email PharmaNewsSales@informa.com